# Efficacy and Safety Study of ATs in Patients With Dry Eye Syndrome

> **NCT00788229** · PHASE2 · COMPLETED · sponsor: **Dhp Korea Co., Ltd.** · enrollment: 72 (actual)

## Conditions studied

- Dry Eye Syndromes
- Keratoconjunctivitis Sicca

## Interventions

- **DRUG:** AT01
- **DRUG:** AT02
- **DRUG:** AT03
- **DRUG:** AT04

## Key facts

- **NCT ID:** NCT00788229
- **Lead sponsor:** Dhp Korea Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-11
- **Primary completion:** 2009-08
- **Final completion:** 2009-08
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2010-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00788229

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00788229, "Efficacy and Safety Study of ATs in Patients With Dry Eye Syndrome". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00788229. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*